Cardiac  ||| S:0 E:8 ||| JJ
troponin  ||| S:8 E:17 ||| NN
and  ||| S:17 E:21 ||| CC
skeletal  ||| S:21 E:30 ||| JJ
muscle  ||| S:30 E:37 ||| NN
oxygenation  ||| S:37 E:49 ||| NN
in  ||| S:49 E:52 ||| IN
severe  ||| S:52 E:59 ||| JJ
post-partum  ||| S:59 E:71 ||| JJ
haemorrhage  ||| S:71 E:83 ||| JJ
Cardiac  ||| S:83 E:91 ||| JJ
troponin  ||| S:91 E:100 ||| NN
has  ||| S:100 E:104 ||| VBZ
been  ||| S:104 E:109 ||| VBN
shown  ||| S:109 E:115 ||| VBN
to  ||| S:115 E:118 ||| TO
be  ||| S:118 E:121 ||| VB
elevated  ||| S:121 E:130 ||| VBN
in  ||| S:130 E:133 ||| IN
one-half  ||| S:133 E:142 ||| NN
of  ||| S:142 E:145 ||| IN
the  ||| S:145 E:149 ||| DT
parturients  ||| S:149 E:161 ||| NN
admitted  ||| S:161 E:170 ||| VBN
for  ||| S:170 E:174 ||| IN
post-partum  ||| S:174 E:186 ||| JJ
haemorrhage ||| S:186 E:197 ||| NN
.  ||| S:197 E:199 ||| .
The  ||| S:199 E:203 ||| DT
purpose  ||| S:203 E:211 ||| NN
of  ||| S:211 E:214 ||| IN
the  ||| S:214 E:218 ||| DT
study  ||| S:218 E:224 ||| NN
was  ||| S:224 E:228 ||| VBD
to  ||| S:228 E:231 ||| TO
assess  ||| S:231 E:238 ||| VB
whether  ||| S:238 E:246 ||| IN
increased  ||| S:246 E:256 ||| JJ
cardiac  ||| S:256 E:264 ||| JJ
troponin  ||| S:264 E:273 ||| NN
was  ||| S:273 E:277 ||| VBD
associated  ||| S:277 E:288 ||| VBN
with  ||| S:288 E:293 ||| IN
a  ||| S:293 E:295 ||| DT
simultaneous  ||| S:295 E:308 ||| JJ
alteration  ||| S:308 E:319 ||| NN
in  ||| S:319 E:322 ||| IN
haemoglobin  ||| S:322 E:334 ||| JJ
tissue  ||| S:334 E:341 ||| NN
oxygen  ||| S:341 E:348 ||| NN
saturation  ||| S:348 E:359 ||| NN
in  ||| S:359 E:362 ||| IN
peripheral  ||| S:362 E:373 ||| JJ
muscles  ||| S:373 E:381 ||| NNS
in  ||| S:381 E:384 ||| IN
post-partum  ||| S:384 E:396 ||| JJ
haemorrhage ||| S:396 E:407 ||| NN
.  ||| S:407 E:409 ||| .
Tissue  ||| S:409 E:416 ||| NN
haemoglobin  ||| S:416 E:428 ||| NN
oxygen  ||| S:428 E:435 ||| NN
saturation  ||| S:435 E:446 ||| NN
of  ||| S:446 E:449 ||| IN
thenar  ||| S:449 E:456 ||| JJ
eminence  ||| S:456 E:465 ||| JJ
muscle  ||| S:465 E:472 ||| NN
( ||| S:472 E:473 ||| -LRB-
StO2 ||| S:473 E:477 ||| NNP
)  ||| S:477 E:479 ||| -RRB-
was  ||| S:479 E:483 ||| VBD
measured  ||| S:483 E:492 ||| VBN
via  ||| S:492 E:496 ||| IN
near-infrared  ||| S:496 E:510 ||| JJ
spectroscopy  ||| S:510 E:523 ||| JJ
technology ||| S:523 E:533 ||| NN
.  ||| S:533 E:535 ||| .
Two  ||| S:535 E:539 ||| CD
sets  ||| S:539 E:544 ||| NNS
of  ||| S:544 E:547 ||| IN
StO2  ||| S:547 E:552 ||| CD
parameters  ||| S:552 E:563 ||| NNS
( ||| S:563 E:564 ||| -LRB-
both  ||| S:564 E:569 ||| DT
isolated  ||| S:569 E:578 ||| JJ
baseline  ||| S:578 E:587 ||| NN
and  ||| S:587 E:591 ||| CC
during  ||| S:591 E:598 ||| IN
forearm  ||| S:598 E:606 ||| JJ
ischaemia-reperfusion  ||| S:606 E:628 ||| JJ
tests ||| S:628 E:633 ||| NNS
)  ||| S:633 E:635 ||| -RRB-
were  ||| S:635 E:640 ||| VBD
collected  ||| S:640 E:650 ||| VBN
at  ||| S:650 E:653 ||| IN
two  ||| S:653 E:657 ||| CD
time  ||| S:657 E:662 ||| NN
points ||| S:662 E:668 ||| NNS
:  ||| S:668 E:670 ||| :
upon  ||| S:670 E:675 ||| IN
intensive  ||| S:675 E:685 ||| JJ
care  ||| S:685 E:690 ||| NN
unit  ||| S:690 E:695 ||| NN
admission  ||| S:695 E:705 ||| NN
and  ||| S:705 E:709 ||| CC
prior  ||| S:709 E:715 ||| RB
to  ||| S:715 E:718 ||| TO
intensive  ||| S:718 E:728 ||| JJ
care  ||| S:728 E:733 ||| NN
unit  ||| S:733 E:738 ||| NN
discharge ||| S:738 E:747 ||| NN
.  ||| S:747 E:749 ||| .
Comparisons  ||| S:749 E:761 ||| NNS
were  ||| S:761 E:766 ||| VBD
performed  ||| S:766 E:776 ||| VBN
using  ||| S:776 E:782 ||| VBG
Wilcoxon  ||| S:782 E:791 ||| JJ
paired  ||| S:791 E:798 ||| JJ
tests ||| S:798 E:803 ||| NNS
,  ||| S:803 E:805 ||| ,
and  ||| S:805 E:809 ||| CC
univariate  ||| S:809 E:820 ||| JJ
associations  ||| S:820 E:833 ||| NNS
were  ||| S:833 E:838 ||| VBD
assessed  ||| S:838 E:847 ||| VBN
using  ||| S:847 E:853 ||| VBG
logistic  ||| S:853 E:862 ||| JJ
regression  ||| S:862 E:873 ||| JJ
model  ||| S:873 E:879 ||| NN
and  ||| S:879 E:883 ||| CC
Wald  ||| S:883 E:888 ||| NNP
tests ||| S:888 E:893 ||| NNS
.  ||| S:893 E:895 ||| .
The  ||| S:895 E:899 ||| DT
42  ||| S:899 E:902 ||| CD
studied  ||| S:902 E:910 ||| JJ
parturients ||| S:910 E:921 ||| NN
,  ||| S:921 E:923 ||| ,
admitted  ||| S:923 E:932 ||| VBN
for  ||| S:932 E:936 ||| IN
post-partum  ||| S:936 E:948 ||| JJ
haemorrhage ||| S:948 E:959 ||| NN
,  ||| S:959 E:961 ||| ,
had  ||| S:961 E:965 ||| VBD
clinical  ||| S:965 E:974 ||| JJ
and  ||| S:974 E:978 ||| CC
biological  ||| S:978 E:989 ||| JJ
signs  ||| S:989 E:995 ||| NNS
of  ||| S:995 E:998 ||| IN
severe  ||| S:998 E:1005 ||| JJ
blood  ||| S:1005 E:1011 ||| NN
loss ||| S:1011 E:1015 ||| NN
.  ||| S:1015 E:1017 ||| .
Initial  ||| S:1017 E:1025 ||| JJ
cardiac  ||| S:1025 E:1033 ||| JJ
troponin  ||| S:1033 E:1042 ||| NN
I  ||| S:1042 E:1044 ||| PRP
was  ||| S:1044 E:1048 ||| VBD
increased  ||| S:1048 E:1058 ||| VBN
in  ||| S:1058 E:1061 ||| IN
24 ||| S:1061 E:1063 ||| CD
/ ||| S:1063 E:1064 ||| CD
42  ||| S:1064 E:1067 ||| CD
parturients  ||| S:1067 E:1079 ||| NNS
( ||| S:1079 E:1080 ||| -LRB-
0.43  ||| S:1080 E:1085 ||| CD
+ ||| S:1085 E:1086 ||| CD
/ ||| S:1086 E:1087 ||| CD
-  ||| S:1087 E:1089 ||| :
0.60  ||| S:1089 E:1094 ||| CD
microrg ||| S:1094 E:1101 ||| CD
/ ||| S:1101 E:1102 ||| CD
l ||| S:1102 E:1103 ||| CD
) ||| S:1103 E:1104 ||| -RRB-
.  ||| S:1104 E:1106 ||| .
All  ||| S:1106 E:1110 ||| DT
measured  ||| S:1110 E:1119 ||| JJ
parameters  ||| S:1119 E:1130 ||| NNS
of  ||| S:1130 E:1133 ||| IN
muscular  ||| S:1133 E:1142 ||| FW
haemoglobin  ||| S:1142 E:1154 ||| FW
oxygen  ||| S:1154 E:1161 ||| FW
saturation ||| S:1161 E:1171 ||| FW
,  ||| S:1171 E:1173 ||| ,
including  ||| S:1173 E:1183 ||| VBG
Srecovery ||| S:1183 E:1192 ||| NNP
,  ||| S:1192 E:1194 ||| ,
were  ||| S:1194 E:1199 ||| VBD
also  ||| S:1199 E:1204 ||| RB
altered  ||| S:1204 E:1212 ||| VBN
at  ||| S:1212 E:1215 ||| IN
admission  ||| S:1215 E:1225 ||| NN
and  ||| S:1225 E:1229 ||| CC
improved  ||| S:1229 E:1238 ||| VBN
together  ||| S:1238 E:1247 ||| RP
with  ||| S:1247 E:1252 ||| IN
improved  ||| S:1252 E:1261 ||| JJ
haemodynamics ||| S:1261 E:1274 ||| NN
,  ||| S:1274 E:1276 ||| ,
when  ||| S:1276 E:1281 ||| WRB
bleeding  ||| S:1281 E:1290 ||| NN
was  ||| S:1290 E:1294 ||| VBD
controlled ||| S:1294 E:1304 ||| VBN
.  ||| S:1304 E:1306 ||| .
Multivariate  ||| S:1306 E:1319 ||| JJ
analysis  ||| S:1319 E:1328 ||| NN
showed  ||| S:1328 E:1335 ||| VBD
that  ||| S:1335 E:1340 ||| DT
muscular  ||| S:1340 E:1349 ||| JJ
Srecovery  ||| S:1349 E:1359 ||| NNP
< ||| S:1359 E:1360 ||| SYM
3 ||| S:1360 E:1361 ||| CD
% ||| S:1361 E:1362 ||| NN
/ ||| S:1362 E:1363 ||| CD
second  ||| S:1363 E:1370 ||| JJ
at  ||| S:1370 E:1373 ||| IN
admission  ||| S:1373 E:1383 ||| NN
was  ||| S:1383 E:1387 ||| VBD
strongly  ||| S:1387 E:1396 ||| RB
associated  ||| S:1396 E:1407 ||| VBN
with  ||| S:1407 E:1412 ||| IN
increased  ||| S:1412 E:1422 ||| JJ
cardiac  ||| S:1422 E:1430 ||| JJ
troponin ||| S:1430 E:1438 ||| NN
.  ||| S:1438 E:1440 ||| .
Our  ||| S:1440 E:1444 ||| PRP$
study  ||| S:1444 E:1450 ||| NN
confirmed  ||| S:1450 E:1460 ||| VBD
the  ||| S:1460 E:1464 ||| DT
high  ||| S:1464 E:1469 ||| JJ
incidence  ||| S:1469 E:1479 ||| NN
of  ||| S:1479 E:1482 ||| IN
increased  ||| S:1482 E:1492 ||| JJ
cardiac  ||| S:1492 E:1500 ||| JJ
troponin ||| S:1500 E:1508 ||| NN
,  ||| S:1508 E:1510 ||| ,
and  ||| S:1510 E:1514 ||| CC
demonstrated  ||| S:1514 E:1527 ||| VBD
the  ||| S:1527 E:1531 ||| DT
simultaneous  ||| S:1531 E:1544 ||| JJ
impairment  ||| S:1544 E:1555 ||| NN
in  ||| S:1555 E:1558 ||| IN
the  ||| S:1558 E:1562 ||| DT
reserve  ||| S:1562 E:1570 ||| NN
of  ||| S:1570 E:1573 ||| IN
oxygen  ||| S:1573 E:1580 ||| JJ
delivery  ||| S:1580 E:1589 ||| NN
to  ||| S:1589 E:1592 ||| TO
peripheral  ||| S:1592 E:1603 ||| JJ
muscles  ||| S:1603 E:1611 ||| NNS
in  ||| S:1611 E:1614 ||| IN
parturients  ||| S:1614 E:1626 ||| VBG
admitted  ||| S:1626 E:1635 ||| VBN
for  ||| S:1635 E:1639 ||| IN
severe  ||| S:1639 E:1646 ||| JJ
post-partum  ||| S:1646 E:1658 ||| JJ
haemorrhage ||| S:1658 E:1669 ||| NN
.  ||| S:1669 E:1671 ||| .
